Scientists have glimpsed proteins turning into the distinctive clumps of Alzheimer’s disease, an action that takes a millisecond or less, providing researchers with clues on drugs to target the ailment. This stage when amyloid beta clumps begin to form may be a crucial place to target preventive medicines, said Michele Vedruscolo, the study author and a biophysicist at the University of Cambridge in the U.K. Today’s finding, published in the journal Science, could lead to “a statin for neurodegenerative disease,” he said.
